Groww Logo
Home>US Stocks>Illumina Inc

Illumina Inc

Healthcare
$240.75
+ $0.94 (0.39%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $235.76$240.757971,127,510

      Fundamentals

      Market Cap$37.82B
      P/B Ratio3.5
      P/E Ratio54
      Enterprise Value$39.01B
      Div. Yield0.00%
      Book Value69.39
      EPS(TTM)4.59
      ROE7.50%
      Understand Fundamentals

      About the Company

      Headquartered in San Diego, California, Illumina, Inc. is a company that develops, manufactures and markets integrated systems for various biotechnological researches. It has a workforce of over 7,300 employees in its 17 commercial and two manufactur
      Headquartered in San Diego, California, Illumina, Inc. is a company that develops, manufactures and markets integrated systems for various biotechnological researches. It has a workforce of over 7,300 employees in its 17 commercial and two manufacturing, research and development operations. Internationally it has offices in 11 locations, namely Singapore, China, France, the Netherlands, Korea, Germany, Japan, Canada, Latin America and the United Kingdom. The company conducts research regarding five subjects that are Complex Disease, Agrigenomics, Microbiology, Cellular and Molecular Biology and Cancer. It also offers clinical assistance for oncology, reproductive health and genetic & rare diseases. Illumina’s technology has helped in the generation of over 90% of the world’s sequencing data. It serves seven industries including government agencies, biotechnology companies, pharmaceutical companies, consumer genetics companies, universities and academic research centres, genome centres and hospitals. It offers products such as kits & reagents, instruments, selection tools and software & analysis. Some of its popular products are Illumina COVIDSeq test, AmpliSeq for Illumina, TruSight Oncology 500 product family, Illumina DNA prep, NextSeq 2000 Sequencing System and Illumina RNA Prep with Enrichment. The company was formed in 1998 by five people named Anthony Czarnik, Larry Bock, Mark Chee, David Walt and John Stuelpnagel. It started to acquire several businesses and expand its reach within a year, beginning with Spyder Instruments. Its first system was launched in 2002 called the Illumina BeadLab. Till 2020, the company has acquired Solexa in 2007, Epicentre Biotechnologies in 2011, and Enancio and Grail in 2020. In 2000, Illumina completed its initial public offering (IPO) and started to trade in the NASDAQ stock exchange under ILMN as its ticker symbol. As of 2020, it is a component in both NASDAQ 100 and S&P 500 lists. It is the 47th company in the 2020 Fortune Future 50 companies and the 687th in Fortune 1000 companies’ lists. Forbes has also recognised it in 2020 lists such as Global 2000 and World’s Best Employers. It also made it into the 2021 Forbes list of Just Companies and ranked 67th.
      ...Read more
      OrganisationIllumina Inc
      IndustryDiagnostics & Research
      HeadQuartersSan Diego, CA

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Illumina Inc

      Can I Buy Illumina Inc Shares in India?

      Yes, Illumina Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy Illumina Inc Shares in India?

      One can easily invest in Illumina Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Illumina Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Illumina Inc.

      What is the Share Price of Illumina Inc?

      The share price of Illumina Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Illumina Inc share price is $240.75 as of 20 May ‘22

      What is the Market Cap of Illumina Inc?

      The Illumina Inc market cap is $37.82B as of 20 May ‘22

      What is the PE and PB ratio of Illumina Inc?

      The PE and PB ratio of Illumina Inc is 54 and 3.5 as of 20 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.8
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW